Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter


(Image Credit: AdobeStock/Pixel-Shot)

AAO 2025 delivered major insights into anterior segment innovation, spanning corneal cross-linking care, refractive surgery evolution, and energy-based aesthetic technology. Presentations from Reena Gupta, MD; Arjan Hura, MD; and James Chelnis, MD, FACS, collectively showcased a field embracing personalization, patient comfort, and advanced energy delivery.
Reena Gupta’s retrospective study comparing bandage contact lenses versus cryopreserved amniotic membrane (AM) after corneal cross-linking (CXL) provided one of the meeting’s most clinically actionable insights.
The findings were striking:
Though patients experience more initial discomfort with AM due to its rigid ring, the overall safety and healing advantages were clear. For advanced keratoconus—where contact lens fitting is often poor—the AM’s uniform surface support may offer a safer and more consistent postoperative environment.
Gupta suggested that AM could become a new standard, especially for early keratoconus patients where postoperative complications carry lifelong implications.
Arjan Hura, MD, presented an exciting refractive milestone: next-generation, ray-trace–enabled WaveLight Plus LASIK, capable of producing unprecedented visual acuity.
Hura noted that many patients now achieve 20/10 vision as early as day one, and importantly—they can perceive the difference from 20/20. The technology accounts for each patient’s optical system in a customized, physics-based manner, representing a new chapter in refractive precision.
Hura emphasized several principles:
High myopes may be steered toward EVO ICL for reversibility and nighttime visual quality, while mid-40s patients might be better suited for refractive lens exchange.
His theme was consistent: refractive surgery is becoming more ethical, more customized, and more transparent.
James Chelnis, MD, FACS, addressed the booming demand for aesthetic periocular and facial treatments. His course outlined how ophthalmologists can safely adopt technologies like:
Chelnis underscored two keys: deconstructing the patient’s problem and building cross-modality treatment plans. For example, MGD with eyelid laxity may require both meibum-quality improvement and mechanical blink enhancement via dynamic stimulation.
He also emphasized safety infrastructure: laser safety training for all staff, dedicated protocols, and careful device selection based on reputation, R&D investment, and iteration maturity.
A particularly exciting takeaway was how rapidly these technologies are becoming safer for diverse skin types. Chelnis noted that ablative treatments for darker skin, once considered too risky, are now possible with proper platforms.
Innovations in the cornea and ocular adnexa continue to push the boundaries of comfort, customization, and cosmetic integration:
AAO 2025 emphasized that anterior-segment care is becoming increasingly holistic—blending functional, refractive, and cosmetic outcomes into a unified patient experience.
Source: www.ophthalmologytimes.com
Author: | Date: 2025-11-28 11:00:00